Cst3 (Cystatin C) Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Cystatin C is a 13.3 kDa secreted cysteine protease inhibitor belonging to the type 2 cystatin family. The protein has a characteristic cystatin-like fold:
N-terminal signal peptide for secretion
Highly conserved N-terminal region required for protease inhibition
Two hairpin loops that interact with target proteases
Forms dimers and tetramers in solution
Normal Function
Cystatin C is a potent inhibitor of cysteine proteases including cathepsins B, H, L, and S:
...
CST3 (Cystatin C) Protein
Introduction
Cst3 (Cystatin C) Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Cystatin C is a 13.3 kDa secreted cysteine protease inhibitor belonging to the type 2 cystatin family. The protein has a characteristic cystatin-like fold:
N-terminal signal peptide for secretion
Highly conserved N-terminal region required for protease inhibition
Two hairpin loops that interact with target proteases
Forms dimers and tetramers in solution
Normal Function
Cystatin C is a potent inhibitor of cysteine proteases including cathepsins B, H, L, and S:
Primary functions:
Protease inhibition: Regulates cathepsin activity in extracellular spaces
Antimicrobial defense: Part of the innate immune system
Regulation of bone resorption: Modulates cathepsin K activity in osteoclasts
Extracellular protein homeostasis
Expression:
Ubiquitously expressed
High expression in brain ([neurons](/entities/neurons) and glia)
Found in all body fluids
neurodegeneration" style="color:#4fc3f7;margin:1.5rem 0 0.6rem;font-size:1.15rem;font-weight:700;border-bottom:2px solid rgba(79,195,247,0.3);padding-bottom:0.3rem">Role in Neurodegeneration
Alzheimer's Disease
CST3 is a genetic risk factor for AD (protective variant A/A at position 42)
The A allele produces less cystatin C and is associated with reduced AD risk
Cystatin C co-localizes with amyloid plaques
May modulate [Aβ](/proteins/amyloid-beta) aggregation
Altered CSF levels in AD patients
Parkinson's Disease
Cystatin C levels are altered in PD
May protect against dopaminergic neuron loss
Genetic variants associated with PD risk
Cerebral Amyloid Angiopathy
Cystatin C deposits in cerebral vessels
Hereditary cerebral amyloid angiopathy (Icelandic type) caused by CST3 mutation
Cystatin C as a biomarker for neurodegenerative diseases
Gene therapy approaches to modulate cystatin C levels
Key Publications
Gauthier S, et al. (2011). "Cystatin C as a potential biomarker for Alzheimer's disease." Curr Alzheimer Res. 8(2):125-131.
Skerget K, et al. (2010). "Cystatin C and risk of dementia: a population-based study." Dement Geriatr Cogn Disord. 30(3):277-281.
Mathews PM, et al. (2000). "Cystatin C, a protective protein in neurodegeneration." Mol Neurobiol. 21(1-2):61-66.
Background
The study of Cst3 (Cystatin C) Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
CST3 encodes Cystatin C, a cysteine protease inhibitor that plays important roles in protein regulation and has been implicated in Alzheimer's disease and cerebral amyloid angiopathy.